Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? (Q37863460)

24 August 2017

1 reference

title

Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? (English)

1 reference

24 August 2017

main subject

regenerative medicine

1 reference

M E Bernardo

1

1 reference

24 August 2017

D Pagliara

series ordinal

2

1 reference

24 August 2017

F Locatelli

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

11 April 2011

1 reference

Bone Marrow Transplantation

24 August 2017

published in

1 reference

24 August 2017

volume

47

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

164-171

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2011.81

24 August 2017

exact match

0 references

cites work

Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Mesenchymal stem cells: clinical applications and biological characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Treatment of neural injury with marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Intravenous transplantation of mesenchymal stem cells improves cardiac performance after acute myocardial ischemia in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Recent advances into the understanding of mesenchymal stem cell trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Potential risks of bone marrow cell transplantation into infarcted hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Mesenchymal stem cell therapy: Two steps forward, one step back

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Therapeutic potential of mesenchymal stem cells for severe acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

SSEA-4 identifies mesenchymal stem cells from bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Repair of large bone defects with the use of autologous bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Novel markers for the prospective isolation of human MSC

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.81

7 January 2021

Identifiers

DOI

10.1038/BMT.2011.81

1 reference

24 August 2017

1 reference